Lead Product(s) : Iopamidol
Therapeutic Area : Endocrinology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Thyroid Function of Pediatric Subjects Following Isovue® Administration
Details : Isovue is a Radiolabeled Compounds drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hypothyroidism.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 19, 2018
Lead Product(s) : Iopamidol
Therapeutic Area : Endocrinology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Iopamidol
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Sponsor : Acist Medical Systems
Deal Size : Inapplicable
Deal Type : Inapplicable
Adenosine Contrast CorrELations in Evaluating RevAscularizaTION
Details : Iopamidol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 15, 2018
Lead Product(s) : Iopamidol
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Sponsor : Acist Medical Systems
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Iopamidol
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Nemoto Kyorindo Co, Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Customized Contrast Media Dose Clinical Trial
Details : Iopamidol is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 05, 2015
Lead Product(s) : Iopamidol
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Nemoto Kyorindo Co, Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Iopamidol
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Sponsor : i3 Statprobe
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Iopamidol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 20, 2011
Lead Product(s) : Iopamidol
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Sponsor : i3 Statprobe
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Iopamidol
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Kidney Damage in Patients With Moderate Fall in eGFR
Details : Iopamidol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Coronary Stenosis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 04, 2010
Lead Product(s) : Iopamidol
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Iopamidol
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Kidney Damage In Patients With Severe Fall In eGFR
Details : Iopamidol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Coronary Stenosis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 04, 2010
Lead Product(s) : Iopamidol
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Iopamidol
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Isovue in Peripheral Digital Subtraction Angiography (DSA)
Details : Iopamidol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Arterial Occlusive Diseases.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 25, 2010
Lead Product(s) : Iopamidol
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
